1. 1) Arnsten AF, Pliszka SR. Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders. Pharmacol. Biochem. Behav., 99, 211–216 (2011).
2. 2) Chai G, Governale L, McMahon AW, Trinidad JP, Staffa J, Murphy D. Trends of outpatient prescription drug utilization in U.S. children, 2002-2010. Pediatrics, 130, 23–31 (2012).
3. 3) Foote SL, Bloom FE, Aston-Jones G. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol. Rev., 63, 844–914 (1983).
4. 4) Pickel VM, Segal M, Bloom FE. A radioautographic study of the efferent pathways of the nucleus locus coeruleus. J. Comp. Neurol., 155, 15–41 (1974).
5. 5) Huss M, Chen W, Ludolph AG. Guanfacine extended release: a new pharmacological treatment option in Europe. Clin. Drug Investig., 36, 1–25 (2016).